Prevalence and effect on health-related quality of life of overactive bladder in older americans: Results from the epidemiology of lower urinary tract symptoms study

Journal of the American Geriatrics Society

Volumn 59, Issue 8, 2011, Pages 1465-1470

  Sexton, Chris C ^a   Coyne, Karin S ^a   Thompson, Christine ^a   Bavendam, Tamara ^b   Chen, Chieh I ^b   Markland, Alayne ^c,d  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PFIZER INC   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

HRQL; older adults; overactive; prevalence; urinary bladder

Indexed keywords

PRESCRIPTION DRUG;

AGED; ANXIETY DISORDER; ARTICLE; DEPRESSION; FEMALE; GERIATRIC DISORDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OVERACTIVE BLADDER; PATIENT ATTITUDE; QUALITY OF LIFE; SHORT FORM 12;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INTERNET; MALE; NOCTURIA; QUALITY OF LIFE; UNITED STATES; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE;

EID: 80051791150     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03492.x     Document Type: Article

References (31)

1. Abrams P, Artibani W, Cardozo L, et al,. Reviewing the ICS 2002 terminology report: The ongoing debate. Neurourol Urodyn 2003; 28: 287.
2. Irwin DE, Milsom I, Hunskaar S, et al,. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306-1314, discussion 1314-1305.
3. Stewart WF, Van Rooyen JB, Cundiff GW, et al,. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-336. (Pubitemid 44175300)
4. Coyne KS, Sexton CC, Vats V, et al,. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011; 77: 1081-1087.
5. Coyne KS, Payne C, Bhattacharyya SK, et al,. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: Results from a national community survey. Value Health 2004a; 7: 455-463. (Pubitemid 39038454)
6. Sexton CC, Coyne KS, Vats V, et al,. Impact of overactive bladder on work productivity in the United States: Results from EpiLUTS. Am J Manag Care 2009; 15: S98-S107.
7. Brown JS, Subak LL, Gras J, et al,. Urge incontinence: The patient's perspective. J Womens Health 1998; 7: 1263-1269.
8. Robinson D, Pearce KF, Preisser JS, et al,. Relationship between patient reports of urinary incontinence symptoms and quality of life measures. Obstet Gynecol 1998; 91: 224-228. (Pubitemid 28074152)
9. MacDiarmid S, Rosenberg M., Overactive bladder in women: Symptom impact and treatment expectations. Curr Med Res Opin 2005; 21: 1413-1421. (Pubitemid 41368573)
10. Coyne KS, Sexton CC, Thompson CL, et al,. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: Results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009a; 104: 352-360.
11. Coyne KS, Wein AJ, Tubaro A, et al,. The burden of lower urinary tract symptoms: Evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009b; 103 (Suppl 3): 4-11.
12. Coyne KS, Sexton CC, Kopp Z, et al,. Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: Results of qualitative research. IJCP 2010, 1-37.
13. Haylen BT, de Ridder D, Freeman RM, et al,. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.
14. Coyne KS, Matza LS, Kopp Z, et al,. The validation of the patient perception of bladder condition (PPBC): A single-item global measure for patients with overactive bladder. Eur Urol 2006; 49: 1079-1086. (Pubitemid 43673993)
15. Bjelland I, Dahl AA, Haug TT, et al,. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77. (Pubitemid 34192886)
16. Lowe B, Spitzer RL, Grafe K, et al,. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78: 131-140. (Pubitemid 38045472)
17. Ware J, Kosinski M, Keller S., SF12. How to Score the SF12 Physical and Mental Health Summary Scales. Boston: The Health Institute, New England Medical Center, 1995.
18. Coyne KS, Lai J-S, Zycyzynski T, et al,. An overactive bladder symptom and quality-of-life short form: Development of the Overactive Bladder Questionnaire Short Form (OAB-q SF). 34th Joint Meeting of the International Continence Society and the International Urogynecological Association. Paris, France, 2004b.
19. Milsom I, Abrams P, Cardozo L, et al,. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-766. (Pubitemid 34204313)
20. Malmsten UG, Molander U, Peeker R, et al,. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: A longitudinal population-based survey in men aged 45-103 years. Eur Urol 2010; 58: 149-156.
21. Cheung WW, Blank W, Borawski D, et al,. Prevalence of overactive bladder, its under-diagnosis, and risk factors in a male urologic veterans population. Int J Med Sci 2010; 7: 391-394.
22. Tikkinen KA, Tammela TL, Rissanen AM, et al,. Is the prevalence of overactive bladder overestimated? A population-based study in Finland. PLoS One 2007; 2: e195.
23. Bartoli S, Aguzzi G, Tarricone R., Impact on quality of life of urinary incontinence and overactive bladder: A systematic literature review. Urology 2010; 75: 491-500.
24. Smith AL, Nissim HA, Le TX, et al,. Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology 2011; 77: 55-59.
25. Kraus SR, Bavendam T, Brake T, et al,. Vulnerable elderly patients and overactive bladder syndrome. Drugs Aging 2010; 27: 697-713.
26. Wyman JF, Burgio KL, Newman DK., Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract 2009; 63: 1177-1191.
27. Chapple C, DuBeau C, Ebinger U, et al,. Darifenacin treatment of patients >or=65 years with overactive bladder: Results of a randomized, controlled, 12-week trial. Curr Med Res Opin 2007; 23: 2347-2358. (Pubitemid 350033436)
28. Malone-Lee JG, Walsh JB, Maugourd MF., Tolterodine: A safe and effective treatment for older patients with overactive bladder. J Am Geriatr Soc 2001; 49: 700-705. (Pubitemid 32652460)
29. Staskin DR., Overactive bladder in the elderly: A guide to pharmacological management. Drugs Aging 2005; 22: 1013-1028. (Pubitemid 41821440)
30. NCQA. The State of Health Care Quality. Washington, DC: National Committee for Quality Assurance, 2009.
31. Weiss CO, Boyd CM, Yu Q, et al,. Patterns of prevalent major chronic disease among older adults in the United States. JAMA 2007; 298: 1160-1162. (Pubitemid 47403117)